Navigation Links
CryoCor Reports 2007 Results
Date:3/20/2008

2007 2006 2007 2006

(Unaudited)

Revenue:

Product revenue $74 $54 $258 $540

Collaboration revenue 166 - 333 -

Total revenue 240 54 591 540

Operating expenses:

Cost of revenue(1) 748 616 2,710 2,468

Research and development(1) 1,740 1,540 7,439 5,835

Selling, general and

administrative(1) 2,044 1,742 6,088 7,360

Total costs and expenses 4,532 3,898 16,237 15,663

Loss from operations (4,292) (3,844) (15,646) (15,123)

Interest income 181 264 883 1,147

Interest expense (240) (268) (993) (1,076)

Net loss (4,351) (3,848) (15,756) (15,052)

Basic and diluted net loss per

common share $(0.35) $(0.36) $(1.31) $(1.40)

Shares used to compute basic and

diluted net loss per common share 12,565 10,912 12,002 10,773

(1) Includes non-cash stock-based

compensation expense as follows:

Cost of revenue $107 $107 $431 $411

Research and development 171 135 682 497

Selling, general and administrative 212 550 849 1,418

$490 $792 $1,962 $2,326


'/>"/>
SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. CryoCor Announces Web cast and Conference Call of 2007 Year End Results
2. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
3. Dr. Warren Jackman Joins CryoCor Scientific Advisory Board
4. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
5. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
6. CryoCor Files Response to Patent Infringement Lawsuit
7. CryoCor Announces Web cast and Conference Call of Third Quarter 2007 Results
8. CryoCor Appoints New Vice President of Sales and Marketing
9. CryoCor to Present at Maxim Group First Annual Growth Conference in New York
10. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
11. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 Real Time Pain Relief ... products, today announced their best-selling lotion is now available in ... Relief is an FDA registered OTC pain relief product. It ... such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu Oil, Glucosamine, ... Menthol – only 1.25% – to avoid buildup of Substance ...
(Date:5/28/2015)... The Khanna Vision Institute announced the ... to make learning about treatment of keratoconus fun. ... years. This proliferation of treatment techniques has not reached ... the nuances of the cutting edge technologies. Dr.Khanna, medical ... can be boring and printed material can be onerous ...
(Date:5/28/2015)... Optimity Advisors ( Optimity ) – ... care for healthcare organizations worldwide – today announced ... operationalize contracting and engagement models. As part of ... of seven “ OrangePapers” that provide actionable ... a strategy, operations and information technology advisory firm ...
(Date:5/28/2015)... The drug epidemic has struck the New ... on May 12th, 2015, by Bradenton , the campus ... The first victim, Dylan Besser (21) was a University of ... The second overdose victim, Julian Toomsen-Hall (18) was also pronounced ... overdose deaths on campus, the college has created a drug ...
(Date:5/28/2015)... The report “Dystonia – Pipeline Review, ... development for Dystonia. Dystonia is characterized by persistent ... movements, postures, or both. Dystonia affects men, women, ... report strengthens R&D pipelines by identifying new targets ... Complete report on H1 2015 pipeline review of ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... SPF 30: First Scar Product to Receive AAD ... American Academy of Dermatology (AAD) has honored Merz ... product for its sun-protection benefit. The AAD SEAL ... benefit based on review of independent testing results ...
... (May 27, 2009) Kevin Bruhn, PhD, is the winner ... honor aimed at nurturing excellence and providing support for a ... Bruhn came to LA BioMed in 2005 after receiving his ... of California, Los Angeles in 2004 and completing a postdoctoral ...
... Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ), ... commercialization of proprietary products that address important therapeutic needs ... A. Oclassen, President & Chief Executive Officer, is scheduled ... Conference in New York City on Wednesday, June 10, ...
... Therapeutics (NYSE Amex: CXM ) and its ... entitled "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the ... Clinical Trials Symposium at the American Society of Gene ... May 27, 2009. Dr. Barbara K. Sosnowski, Cardium,s ...
... Chemical-Free Cleaning Process Offers Greater than 99.9 Percent Bacterial ... Pro, a convenient hand-held device that offers a breakthrough ... powerful general-purpose cleaner, has now been certified as a ... as directed, the Activeion Pro offers a greater than ...
... May 28 Today, Express Scripts, Inc. (Nasdaq: ... under the Hart-Scott-Rodino Act in connection with its premerger ... of WellPoint, Inc.,s (NYSE: WLP ) NextRx ... This represents a significant step forward towards completion of ...
Cached Medicine News:Health News:American Academy of Dermatology Recognizes Merz Pharmaceuticals 2Health News:American Academy of Dermatology Recognizes Merz Pharmaceuticals 3Health News:American Academy of Dermatology Recognizes Merz Pharmaceuticals 4Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 2Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 3Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 2Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 3Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 4Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 5Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 6Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 7Health News:Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting 8Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 2Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 3Health News:Express Scripts Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of WellPoint's NextRx Subsidiaries 2
(Date:5/28/2015)... Calif. , May 28, 2015  Based ... market, Frost & Sullivan recognizes Lexmark Healthcare ... Sullivan Award for Company of the Year in ... take HCM to the next level of interoperability ... acquisitions and followed them up with large-scale product ...
(Date:5/28/2015)... , May 28, 2015  Cardinal Health today ... acquire Johnson & Johnson,s Cordis business for $1.944 billion ... after consultations with relevant works councils and trade unions. ... the United States and key non-U.S. countries ... and other customary closing conditions. Headquartered in ...
(Date:5/28/2015)... 2015  Trovagene, Inc., (NASDAQ: TROV ) ... the launch of its "Yellow Is The New ... SM (PCM) service at the American Society ... center on Trovagene,s Clinical Experience Program, in which ... with the Company,s proprietary urinary liquid biopsy tests. ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 2Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 3Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 4
... NEW YORK, March 15, 2012 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0578259/Vaccines---Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This market ... on the actual market situation, trends and ...
... that closes a hole in patients, hearts is no more ... a new study published in the March 15 issue of ... the CLOSURE I trial, clinical researchers compared a catheter procedure ... or transient ischemic attacks (TIAs) in patients between 18 and ...
Cached Medicine Technology:Vaccines - Asia 2Landmark Study Finds Expensive Catheter Procedure to Close Hole in Heart No More Effective Than Medical Therapy to Prevent Strokes 2Landmark Study Finds Expensive Catheter Procedure to Close Hole in Heart No More Effective Than Medical Therapy to Prevent Strokes 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: